September 2014

CMR verified myocarditis leads to lower EF at 12 months ()
CKD does not indicate extra bleeding risks in stroke treatment ()
Education, justification & optimization get to heart of safe imaging ()
Unbalanced: Women die more often after STEMI PCI ()
Handheld ultrasound trounces physical exams for accuracy, cost ()
More than a pain: NSAIDs may raise VTE risk ()
Infraredx receives regulatory approval of TVC Imaging System in Japan ()
AliveCor launches new app to auto detect atrial fibrillation in an ECG recording ()
Postoperative cardiac events increased in sleep apnea patients ()
Asthma drug elevates cardiovascular risk ()
Compressions in CPR: Guidelines may need to dial back ()
Defense awards $67M for airworthy defibrillators ()
Cardiologist pays $200K to settle kickback case ()
LabCorp pays $85.3M to add LDL testing to its portfolio ()
Blood, sweat & time: Why heart surgeons make more than family doctors ()
Making guidelines an ally ()
Drawing blood and feds' suspicion, too ()
Lipid recommendations fill cholesterol guidelines’ black holes ()
Debate is on: On-site vs. hospital treatment for cardiac arrest ()
ACC takes revascularization off its ‘beware’ list ()
Kaiser Permanente awards $2.55 million grant to American Heart Association initiative to address high blood pressure among African-Americans ()
Boston Scientific enrolls first patients In U.S. trial of the Lotus Valve System ()
Guideline updates: Goodbye NSTEMI, hello NSTE-ACS ()
Repositionable Lotus valve safe, effective at 30 days ()
Following AHA guidelines cuts telemetry costs by $13K a day ()
Statins significantly improve 30-day outcomes in ICH study ()
Study finds 4 out of 5 MIs preventable with healthy lifestyle ()
Pilot program to use HealthKit app to flag heart failure problems ()
Medtronic announces CE mark and European launch of TYRX(TM) Absorbable Antibacterial Envelope ()
Pharmacies to offer rivaroxaban starter packs ()
TCT.14: Radiation management, from no tech to high tech ()
Rates of stroke following acute MI drop as treatments improve ()
End users & EHRs: The cardiologists’ viewpoint ()
St. Jude puts Portico on hold ()
CABG raises quality of life in patients with ischemic left ventricular dysfunction ()
GE Healthcare installs Cath Lab Efficiency Manager, a new IT solution to improve performance measurement in the interventional lab ()
As TAVR marches forward ()
Sanofi and MyoKardia announce groundbreaking collaboration to develop targeted therapies for patients with genetic heart disease ()
Abbott initiates ABSORB IV trial to evaluate quality of life and cost savings of dissolving heart device ()
TCT.14: A case of reimbursement blues and how to avoid them ()
Generic statins increase adherence, improve outcomes ()
Amgen presents analyses of Phase 3 Ivabradine data for the treatment of chronic heart failure ()
ACIST launches HDi high-definition IVUS ()
InspireMD announces positive results from CGuard CARENET trial with 0% MACE reported at 30 days ()
Willis-Knighton Health System selects Merge Cardiology and Interoperability Solutions for enterprise imaging, advanced clinical reporting and simplified workflow ()
Review of thromboembolism treatments finds one laggard, two contenders ()
TCT.14: Successful valve practices embrace change ()
Medtronic launches SEEQ wearable cardiac monitoring system in United States ()
Cardiac Dimensions announces new long-term outcomes data from TITAN II clinical trial demonstrates safety, efficacy of Enhanced CARILLON Mitral Contour System ()
Cardioxyl presents oral heart failure treatment data for its experimental HNO prodrug at HFSA 18th annual scientific meeting ()
TCT.14: How to minimize conflict in the cath lab ()
TCT.14: Women interventionalists few but procedurally mighty ()
SCAI names Lisa Olson executive director ()
Amaranth Medical initiates clinical trial of the second-generation FORTITUDE bioresorbable drug-eluting scaffold ()
Medtronic drug-coated balloon shows strong clinical and economic benefit in treatment of peripheral artery disease ()
REPRISE II data demonstrate sustained safety and performance outcomes at one year for the Boston Scientific Lotus Valve System ()
EXCITE ISR proves superiority in safety, efficacy of laser atherectomy with PTA vs. PTA alone; Data presented at TCT 2014 ()
TCT.14: RIBS-IV sheds light on effectiveness of drug-eluting balloons ()
TCT.14: Google Glass debuts in the cath lab ()
TCT.14: Periprocedural complications tag $10K onto TAVR costs ()
TCT.14: Hospitals' future combines closures, opportunities ()
TCT.14: Six-week triple therapy fails to unseat six-month duration ()
TCT.14: DKCRUSH-IV shows simpler is better in side branch stenting ()
TCT.14: Heparin may come back in vogue, but in low doses ()
TCT.14: Drape, cap cut operator’s radiation dose by 75 percent ()
TCT.14: Bioresorbable scaffolds appear safe at one year ()
TCT.14: IVUS-guided PCI beats out angiography for CTOs ()
TCT.14: A Q&A over TAVR’s value proposition ()
TCT.14: TAVR extends survival by two years in inoperable patients ()
New analysis addresses cardiovascular patients with other conditions ()
Shedding light on stroke outcomes with CTA source images and CBV ()
Preventice and eCardio Diagnostics announce strategic combination in cardiac patient monitoring market ()
Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo, and launches product with first commercial implantations ()
Variability in CAD detection questioned in invasive testing study ()
Greyscale IVUS reframes plaque progression in atherosclerosis ()
The importance of keeping afib warfarin control stable ()
Looking beyond the tech at TCT.14 ()
Risks higher for women undergoing STEMI PCI ()
Growing up on statins: Checking up on kids 10 years out ()
Playtime reduces heart failure risk ()
When measuring novel anticoagulants, proceed with caution ()
Plaque texture and volume indicative of vascular risk ()
TCT.14: Stents and TAVR, keynote speakers highlighted ()
Afib patients living longer with ablation-maintained sinus rhythm ()
SOLID-TIMI 52: Darapladib a dud for acute coronary syndrome ()
Best warfarin time in therapeutic range achieved using algorithm ()
Treating stroke with r-tPA saves payers $25,000 per patient ()
PET helps ID at-risk patients after heart transplants ()
REVIVE SE thrombectomy device approved for ischemic stroke patients in China, South Korea and Taiwan ()
Patient enrollment completed in landmark CLEAN-TAVI clinical trial studying the role of cerebral protection in reducing cerebrovascular events ()
FDA panel to rule on blood pressure combo drug ()
Get With The Guidelines' newest kid on the block: Afib ()
Did guidelines affect post-stent surgical outcomes? ()
Early ticagrelor treatment safe but it doesn’t improve reperfusion ()
Medtronic announces CE mark for recapturable CoreValve Evolut R System ()
Heart failure patients with afib get little benefit from beta-blockers ()
ESC Hot Line: Data reports NVAF patients taking Pradaxa (dabigatran etexilate mesylate) experienced slower decline in kidney function compared to those on warfarin ()
TAVR: Raising the Bar to Achieve Good Outcomes ()
CT-based Mobile Stroke Care ()
Diving into Finances to Improve Care ()
No Margin, No Mission: A Team-Based Approach to Cath Lab Billing ()
Carotid Artery Stenting: Making Progress Amid Reimbursement Purgatory ()
Global survey of cardiologists highlights complexity of managing non-valvular atrial fibrillation and reinforces need for individualized approach to patient care ()
Subgroup analysis of ENGAGE AF-TIMI 48 explores the relationship between edoxaban dose, concentration, anti-Factor Xa activity and outcomes ()
ACC contest to recognize patients living well with heart disease ()
Remote Monitoring & ICDs: Slow Uptake Despite Benefits ()
IN-TIME trial confirms a 50 percent reduction in mortality in heart failure patients while EuroEco and ECOST demonstrate economic savings ()
Biodegradable stent matches gold standard for safety, efficacy ()
Virtual Experts: How Surgery Simulations Are Changing Training ()
Confusion About Guidelines Contributes to Suboptimal LDL Management ()
TCT 2.0: Conference Takes It to the Next Level ()
Successful Service Lines: What You Need to Know ()
Robotically Assisted Mitral Valve Repair: Does It Compute? ()
CABG Readmissions: Not Your Garden Variety Measure ()
FAME 2, Act 2: FFR-guided PCI keeps its lead at 2 years ()